These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17522091)

  • 1. Transgenic mice expressing a fully nontoxic diphtheria toxin mutant, not CRM197 mutant, acquire immune tolerance against diphtheria toxin.
    Kimura Y; Saito M; Kimata Y; Kohno K
    J Biochem; 2007 Jul; 142(1):105-12. PubMed ID: 17522091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diphtheria toxin mutant CRM197 possesses weak EF2-ADP-ribosyl activity that potentiates its anti-tumorigenic activity.
    Kageyama T; Ohishi M; Miyamoto S; Mizushima H; Iwamoto R; Mekada E
    J Biochem; 2007 Jul; 142(1):95-104. PubMed ID: 17525101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the non-toxic mutant of the diphtheria toxin K51E/E148K as carrier protein for meningococcal vaccines.
    Pecetta S; Vijayakrishnan B; Romano MR; Proietti D; Lo Surdo P; Balocchi C; Mori E; Davis BG; Berti F
    Vaccine; 2016 Mar; 34(11):1405-11. PubMed ID: 26845738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine monoclonal antibodies neutralizing the cytotoxic activity of diphtheria toxin.
    Usuwanthim K; Pootong A; Chaisri U; Tongtawe P; Tapchaisri P; Chongsa-Nguan M; Chaicumpa W
    Asian Pac J Allergy Immunol; 2008 Mar; 26(1):47-55. PubMed ID: 18595529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of mouse models for type 1 diabetes by selective depletion of pancreatic beta cells using toxin receptor-mediated cell knockout.
    Matsuoka K; Saito M; Shibata K; Sekine M; Shitara H; Taya C; Zhang X; Takahashi TA; Kohno K; Kikkawa Y; Yonekawa H
    Biochem Biophys Res Commun; 2013 Jul; 436(3):400-5. PubMed ID: 23747725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of diphtheria toxin in Streptococcus mutans and induction of toxin-neutralizing antisera.
    Lee CW; Halperin SA; Morris A; Lee SF
    Can J Microbiol; 2005 Oct; 51(10):841-6. PubMed ID: 16333343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal vaccination against diphtheria using starch microparticles as adjuvant for cross-reacting material (CRM197) of diphtheria toxin.
    Rydell N; Sjöholm I
    Vaccine; 2005 Apr; 23(21):2775-83. PubMed ID: 15780725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and immunogenicity of a recombinant diphtheria toxin fragment A in Streptococcus gordonii.
    Lee CW; Lee SF; Halperin SA
    Appl Environ Microbiol; 2004 Aug; 70(8):4569-74. PubMed ID: 15294787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Cloning, Structural Modeling and the Production of Soluble Triple-Mutated Diphtheria Toxoid (K51E/G52E/E148K) Co-expressed with Molecular Chaperones in Recombinant Escherichia coli.
    Uthailak N; Mahamad P; Chittavanich P; Yanarojana S; Wijagkanalan W; Petre J; Panbangred W
    Mol Biotechnol; 2017 May; 59(4-5):117-127. PubMed ID: 28324209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression, purification and characterization of diphtheria toxin mutant CRM197 in Eschrichia coli].
    Fang T; Tao Z; Liu Y; Yu C; Zhi R; Yu R
    Sheng Wu Gong Cheng Xue Bao; 2018 Apr; 34(4):561-568. PubMed ID: 29701029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan.
    McNeela EA; Jabbal-Gill I; Illum L; Pizza M; Rappuoli R; Podda A; Lewis DJ; Mills KH
    Vaccine; 2004 Feb; 22(8):909-14. PubMed ID: 15161067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of neutralizing antibodies against diphtheria toxin by priming with recombinant Mycobacterium bovis BCG expressing CRM(197), a mutant diphtheria toxin.
    Miyaji EN; Mazzantini RP; Dias WO; Nascimento AL; Marcovistz R; Matos DS; Raw I; Winter N; Gicquel B; Rappuoli R; Leite LC
    Infect Immun; 2001 Feb; 69(2):869-74. PubMed ID: 11159980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the immunogenicity of native and formalinized cross reacting material (CRM197) of diphtheria toxin in mice and guinea pigs and their implications on the development and control of diphtheria vaccine based on CRMs.
    Gupta RK; Collier RJ; Rappuoli R; Siber GR
    Vaccine; 1997; 15(12-13):1341-3. PubMed ID: 9302741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of diphtheria toxin receptor and a nonproteinous diphtheria toxin-binding molecule in Vero cell membrane.
    Mekada E; Okada Y; Uchida T
    J Cell Biol; 1988 Aug; 107(2):511-9. PubMed ID: 3417759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and characterisation of A and B fragments of Corynebacterium diphtheriae toxin towards recombinant diphtheria vaccine.
    Abulmagd S; Emara M; Aziz S; El-Domany R
    Indian J Med Microbiol; 2013; 31(1):3-9. PubMed ID: 23508421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Super-resolution microscopy unveils transmembrane domain-mediated internalization of cross-reacting material 197 into diphtheria toxin-resistant mouse J774A.1 cells and primary rat fibroblasts in vitro.
    Fellermann M; Wondany F; Carle S; Nemeth J; Sadhanasatish T; Frick M; Barth H; Michaelis J
    Arch Toxicol; 2020 May; 94(5):1753-1761. PubMed ID: 32266418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of diphtheria toxin R domain mutants with enhanced inhibitory activity against HB-EGF.
    Suzuki K; Mizushima H; Abe H; Iwamoto R; Nakamura H; Mekada E
    J Biochem; 2015 May; 157(5):331-43. PubMed ID: 25432160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypersensitivity to diphtheria toxin by mouse cells expressing both diphtheria toxin receptor and CD9 antigen.
    Brown JG; Almond BD; Naglich JG; Eidels L
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8184-8. PubMed ID: 8367482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated murine HB-EGF confers sensitivity to diphtheria toxin in EGFR-mutant lung adenocarcinoma.
    Robles-Oteiza C; Ayeni D; Levy S; Homer RJ; Kaech SM; Politi K
    Dis Model Mech; 2021 Nov; 14(11):. PubMed ID: 34494649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically engineered diphtheria toxin fusion proteins carrying the hepatitis B surface antigen.
    Phalipon A; Kaczorek M
    Gene; 1987; 55(2-3):255-63. PubMed ID: 2444498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.